Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings.
Miriam Sobrino-GarcíaFrancisco Javier Muñoz-BellidoEsther Moreno RodillaRita Martín-MuñozAránzazu García-IglesiasIgnacio Dávila GonzálezPublished in: International journal of clinical pharmacy (2024)
Delabeling hospitalized patients represents a cost-saving measure for treating patients labeled as allergic to beta-lactams.